A Johnson & Johnson internal study found that recalled DePuy ASR hip replacements have a 37 percent failure rate after five years of use, according to a recent New York Times article. The Rottenstein Law Group monitors this situation with concern.
The internal study suggests that more of the 37,000 DePuy hip implant recipients in the United States than expected will have to undergo correction and replacement surgeries in the coming years, according to the Times article based on documents unsealed in a DePuy hip lawsuit in Los Angeles Superior Court (In re: Loren Kransky and Sheryl Kransky v. DePuy, Inc., et al., BC456086, Los Angeles Superior Court), the first DePuy hip trial in the country to proceed beyond jury selection.
“This is more evidence of Johnson & Johnson’s breach of consumer trust,” said Rochelle Rottenstein, principal of the Rottenstein Law Group. “DePuy hip replacement recipients thought they were getting relief from hip problems, not more problems.”
Johnson & Johnson subsidiary DePuy recalled the ASR in 2010 and since then more than 10,000 people have sued in state and federal courts in the U.S., according to Bloomberg. As opposed to plastic and metal hip implants, which last 15 years or more prior to wearing out, metal-on-metal models such as the DePuy ASR began to fail in many patients soon after implantation, according to the Times article. One of the primary side effects of the DePuy ASR, according to the Times, is the creation of metal debris from device use. The metal can flake off into the body and cause severe tissue and bone damage.
Read more : DePuy Hip Recall Lawsuit Update: Rottenstein Law Group Concerned by J&J Admission of Increased Hip Implant Failure Rates